Minimally Invasive Resection of Colorectal Cancer Liver Metastases Leads to an Earlier Initiation of Chemotherapy Compared to Open Surgery

Journal of Gastrointestinal Surgery

Volumn 19, Issue 12, 2015, Pages 2199-2206

  Tohme, Samer ^a   Goswami, Julie ^a   Han, Katrina ^a   Chidi, Alexis P ^a   Geller, David A ^a   Reddy, Srinevas ^b   Gleisner, Ana ^a   Tsung, Allan ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b Virginia Piper Cancer Institute   (United States)

Author keywords

Hepatic resection; Laparoscopic liver resection; Metastatic colorectal cancer; Minimally invasive surgery; Postoperative chemotherapy

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; COLORECTAL NEOPLASMS; DISEASE FREE SURVIVAL; DRUG ADMINISTRATION; FEMALE; HUMAN; LENGTH OF STAY; LIVER NEOPLASMS; LIVER RESECTION; MALE; MIDDLE AGED; MINIMALLY INVASIVE SURGERY; MORTALITY; PATHOLOGY; RETROSPECTIVE STUDY; SECONDARY; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEPATECTOMY; HUMANS; LENGTH OF STAY; LIVER NEOPLASMS; MALE; MIDDLE AGED; MINIMALLY INVASIVE SURGICAL PROCEDURES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84947020282     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-015-2962-5     Document Type: Article

References (35)

1. R. L. Siegel, K. D. Miller, and A. Jemal, “Cancer statistics, 2015,” CA Cancer J Clin, vol. 65, pp. 5-29, 2015.
2. S. Manfredi, C. Lepage, C. Hatem, O. Coatmeur, J. Faivre, and A. M. Bouvier, “Epidemiology and management of liver metastases from colorectal cancer,” Ann Surg, vol. 244, pp. 254-9, 2006.
3. E. K. Abdalla, R. Adam, A. J. Bilchik, D. Jaeck, J. N. Vauthey, and D. Mahvi, “Improving resectability of hepatic colorectal metastases: expert consensus statement,” Ann Surg Oncol, vol. 13, pp. 1271-80, 2006.
4. T. A. Aloia, J. N. Vauthey, E. M. Loyer, D. Ribero, T. M. Pawlik, S. H. Wei, et al., “Solitary colorectal liver metastasis: resection determines outcome,” Arch Surg, vol. 141, pp. 460-6; discussion 466-7, 2006.
5. M. A. Choti, J. V. Sitzmann, M. F. Tiburi, W. Sumetchotimetha, R. Rangsin, R. D. Schulick, et al., “Trends in long-term survival following liver resection for hepatic colorectal metastases,” Ann Surg, vol. 235, pp. 759-66, 2002.
6. S. Kopetz, G. J. Chang, M. J. Overman, C. Eng, D. J. Sargent, D. W. Larson, et al., “Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy,” J Clin Oncol, vol. 27, pp. 3677-83, 2009.
7. R. M. Goldberg, D. J. Sargent, R. F. Morton, C. S. Fuchs, R. K. Ramanathan, S. K. Williamson, et al., “Randomized controlled trial of reduced-dose bolus fluorouracil plus leucovorin and irinotecan or infused fluorouracil plus leucovorin and oxaliplatin in patients with previously untreated metastatic colorectal cancer: a North American Intergroup Trial,” J Clin Oncol, vol. 24, pp. 3347-53, 2006.
8. K. T. Nguyen, T. C. Gamblin, and D. A. Geller, “World review of laparoscopic liver resection-2,804 patients,” Ann Surg, vol. 250, pp. 831-41, 2009.
9. K. T. Nguyen and D. A. Geller, “Outcomes of laparoscopic hepatic resection for colorectal cancer metastases,” J Surg Oncol, vol. 102, pp. 975-7, 2010.
10. K. T. Nguyen, A. Laurent, I. Dagher, D. A. Geller, J. Steel, M. T. Thomas, et al., “Minimally invasive liver resection for metastatic colorectal cancer: a multi-institutional, international report of safety, feasibility, and early outcomes,” Ann Surg, vol. 250, pp. 842-8, 2009.
11. K. T. Nguyen, J. W. Marsh, A. Tsung, J. J. Steel, T. C. Gamblin, and D. A. Geller, “Comparative benefits of laparoscopic vs open hepatic resection: a critical appraisal,” Arch Surg, vol. 146, pp. 348-56, 2011.
12. D. Castaing, E. Vibert, L. Ricca, D. Azoulay, R. Adam, and B. Gayet, “Oncologic results of laparoscopic versus open hepatectomy for colorectal liver metastases in two specialized centers,” Ann Surg, vol. 250, pp. 849-55, 2009.
13. A. M. Kazaryan, I. P. Marangos, B. I. Rosok, A. R. Rosseland, O. Villanger, E. Fosse, et al., “Laparoscopic resection of colorectal liver metastases: surgical and long-term oncologic outcome,” Ann Surg, vol. 252, pp. 1005-12, 2010.
14. S. C. Schiffman, K. H. Kim, A. Tsung, J. W. Marsh, and D. A. Geller, “Laparoscopic versus open liver resection for metastatic colorectal cancer: A metaanalysis of 610 patients,”Surgery 2015 157(2):211-22
15. A. Tsung, D. A. Geller, D. C. Sukato, S. Sabbaghian, S. Tohme, J. Steel, et al., “Robotic versus laparoscopic hepatectomy: a matched comparison,” Ann Surg, vol. 259, pp. 549-55, 2014.
16. E. Berber, H. Y. Akyildiz, F. Aucejo, G. Gunasekaran, S. Chalikonda, and J. Fung, “Robotic versus laparoscopic resection of liver tumours,” HPB (Oxford), vol. 12, pp. 583-6, 2010.
17. E. C. Lai, G. P. Yang, and C. N. Tang, “Robot-assisted laparoscopic liver resection for hepatocellular carcinoma: short-term outcome,” Am J Surg, vol. 205, pp. 697-702, 2013.
18. G. Portier, D. Elias, O. Bouche, P. Rougier, J. F. Bosset, J. Saric, et al., “Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial,” J Clin Oncol, vol. 24, pp. 4976-82, 2006.
19. B. Nordlinger, H. Sorbye, B. Glimelius, G. J. Poston, P. M. Schlag, P. Rougier, et al., “Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial,” Lancet, vol. 371, pp. 1007-16, 2008.
20. B. Nordlinger, H. Sorbye, B. Glimelius, G. J. Poston, P. M. Schlag, P. Rougier, et al., “Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial,” Lancet Oncol, vol. 14, pp. 1208-15, 2013.
21. N. Gunduz, B. Fisher, and E. A. Saffer, “Effect of surgical removal on the growth and kinetics of residual tumor,” Cancer Res, vol. 39, pp. 3861-5, 1979.
22. B. Fisher, N. Gunduz, J. Coyle, C. Rudock, and E. Saffer, “Presence of a growth-stimulating factor in serum following primary tumor removal in mice,” Cancer Res, vol. 49, pp. 1996-2001, 1989.
23. M. Baum, R. Demicheli, W. Hrushesky, and M. Retsky, “Does surgery unfavourably perturb the “natural history” of early breast cancer by accelerating the appearance of distant metastases?,” Eur J Cancer, vol. 41, pp. 508-15, 2005.
24. J. J. Biagi, M. J. Raphael, W. J. Mackillop, W. Kong, W. D. King, and C. M. Booth, “Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: a systematic review and meta-analysis,” JAMA, vol. 305, pp. 2335-42, 2011.
25. S. K. Reddy, J. W. Marsh, P. R. Varley, B. K. Mock, K. B. Chopra, D. A. Geller, et al., “Underlying steatohepatitis, but not simple hepatic steatosis, increases morbidity after liver resection: a case-control study,” Hepatology, vol. 56, pp. 2221-30, 2012
26. J. Belghiti, K. Hiramatsu, S. Benoist, P. Massault, A. Sauvanet, and O. Farges, “Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection,” J Am Coll Surg, vol. 191, pp. 38-46, 2000.
27. D. Dindo, N. Demartines, and P. A. Clavien, “Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey,” Ann Surg, vol. 240, pp. 205-13, 2004.
28. T. L. Frankel and M. I. D’Angelica, “Hepatic resection for colorectal metastases,” J Surg Oncol, vol. 109, pp. 2-7, 2014.
29. M. G. House, H. Ito, M. Gonen, Y. Fong, P. J. Allen, R. P. DeMatteo, et al., “Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution,” J Am Coll Surg, vol. 210, pp. 744-52, 752-5, 2010.
30. B. Nordlinger, M. Guiguet, J. C. Vaillant, P. Balladur, K. Boudjema, P. Bachellier, et al., “Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie,” Cancer, vol. 77, pp. 1254-62, 1996.
31. J. S. Tomlinson, W. R. Jarnagin, R. P. DeMatteo, Y. Fong, P. Kornprat, M. Gonen, et al., “Actual 10-year survival after resection of colorectal liver metastases defines cure,” J Clin Oncol, vol. 25, pp. 4575-80, 2007.
32. K. P. Croome, M. B. Farnell, F. G. Que, K. M. Reid-Lombardo, M. J. Truty, D. M. Nagorney, et al., “Total laparoscopic pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: oncologic advantages over open approaches?,” Ann Surg, vol. 260, pp. 633-8; discussion 638-40, 2014.
33. A. R. Day, G. Middleton, R. V. Smith, I. C. Jourdan, and T. A. Rockall, “Time to adjuvant chemotherapy following colorectal cancer resection is associated with an improved survival,” Colorectal Dis, vol. 16, pp. 368-72, 2014.
34. J. H. Wang, T. M. King, M. C. Chang, and C. W. Hsu, “Comparison of the feasibility of laparoscopic resection of the primary tumor in patients with stage IV colon cancer with early and advanced disease: the short- and long-term outcomes at a single institution,” Surg Today, vol. 43, pp. 1116-22, 2013.
35. T. A. Aloia, G. Zimmitti, C. Conrad, V. Gottumukalla, S. Kopetz, and J. N. Vauthey, “Return to intended oncologic treatment (RIOT): a novel metric for evaluating the quality of oncosurgical therapy for malignancy,” J Surg Oncol, vol. 110, pp. 107-14, 2014.